| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $277.1M | +7.7% | +70.9% |
| R&D Expense | $64.0M | -7.0% | -1.3% |
| SG&A Expense | $60.8M | -5.9% | +1.5% |
| Operating Income | $23.7M | +421.0% | +152.4% |
| Income Tax | $124K | +153.1% | +175.6% |
| Net Income | $31.8M | +467.2% | +570.6% |
| EPS (Basic) | $0.33 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $489.8M | +23.7% | — |
| Total Assets | $2.90B | +17.2% | +60.6% |
| Total Liabilities | $2.16B | +23.1% | +78.1% |
| Stockholders' Equity | $743.7M | +3.0% | +24.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$256.3M | — | — |
| Capital Expenditures | $190K | — | — |
| Investing Cash Flow | -$308.9M | — | — |
| Financing Cash Flow | $425.8M | — | — |
| Free Cash Flow | -$256.5M | — | — |
| +450.0% |
| +571.4% |
| EPS (Diluted) | $0.23 | +360.0% | +428.6% |